Please wait while the formulary information is being retrieved.
GRANISETRON HCL (GRANISETRON HCL/PF)
- Prevention of chemotherapy-induced nausea and vomiting
- Post-operative nausea and vomiting
- Prevention of post-operative nausea and vomiting
- Granisetron Iv
- Granisetron Intravenous Solution
- Granisetron Hcl Intravenous Solution
- Granisetron (pf) Iv
- Granisetron (pf) Intravenous Solution
- By Indication
1 mg/mL (1 mL) intravenous solution
- Infuse 10 mcg/kg over 5 minute(s) by intravenous route once daily on days of chemotherapy
1 mg/mL intravenous solution
- Infuse 10 mcg/kg over 5 minute(s) by intravenous route once daily on days of chemotherapy
1 mg/mL (1 mL) intravenous solution
- Infuse 10 mcg/kg over 5 minute(s) by intravenous route once daily on days of chemotherapy
1 mg/mL intravenous solution
- Infuse 10 mcg/kg over 5 minute(s) by intravenous route once daily on days of chemotherapy
1 mg/mL (1 mL) intravenous solution
- Infuse 10 mcg/kg over 5 minute(s) by intravenous route once daily on days of chemotherapy
1 mg/mL intravenous solution
- Infuse 10 mcg/kg over 5 minute(s) by intravenous route once daily on days of chemotherapy
1 mg/mL (1 mL) intravenous solution
- Infuse 10 mcg/kg over 5 minute(s) by intravenous route once daily on days of chemotherapy
100 mcg/mL (0.1 mg/mL) intravenous solution
- Infuse 10 mcg/kg over 30 second(s) by intravenous route undiluted once daily 30 minutes before chemotherapy
granisetron (PF) 1 mg/mL (1 mL) intravenous solution
- Infuse 10 mcg/kg over 5 minute(s) by intravenous route once daily on days of chemotherapy
granisetron (PF) 100 mcg/mL (0.1 mg/mL) intravenous solution
- Infuse 10 mcg/kg over 30 second(s) by intravenous route undiluted once daily 30 minutes before chemotherapy
Cancer chemotherapy-induced nausea and vomiting
- Infuse 10 mcg/kg by intravenous route once
Prevention of chemotherapy-induced nausea and vomiting
- Infuse 10 mcg/kg over 30 second(s) by intravenous route undiluted once daily 30 minutes before chemotherapy
- Infuse 10 mcg/kg over 5 minute(s) by intravenous route once daily on days of chemotherapy
Prevention of radiation-induced nausea and vomiting
- Infuse 10 mcg/kg over 30 second(s) by intravenous route undiluted once daily 30 minutes before chemotherapy
- Infuse 10 mcg/kg over 5 minute(s) by intravenous route once daily on days of chemotherapy
- Apokyn
- apomorphine
Contraindicated
- amiodarone
- amiodarone in dextrose,iso-osm
- artemether-lumefantrine
- Coartem
- Cordarone
- disopyramide
- dronedarone
- droperidol
- Fareston
- Geodon
- Multaq
- Nexterone
- Norpace
- Norpace Cr
- Orap
- Pacerone
- pimozide
- thioridazine
- toremifene
- ziprasidone HCl
- ziprasidone mesylate
Severe
Moderate
- Ablavar
- alfuzosin
- Anzemet
- arsenic trioxide
- Avelox
- Avelox Abc Pack
- Avelox In Nacl (iso-osmotic)
- bedaquiline
- Betapace
- Betapace Af
- Caprelsa
- Celexa
- Cipro
- Cipro In D5W
- Cipro Xr
- ciprofloxacin
- ciprofloxacin (mixture)
- ciprofloxacin in D5W
- citalopram
- clozapine
- Clozaril
- Complera
- Conzip
- crizotinib
- dasatinib
- Diskets
- dofetilide
- dolasetron
- Dolophine
- Edurant
- emtricitab-rilpivirine-tenofov
- eribulin
- escitalopram oxalate
- ezogabine
- Fazaclo
- gadofosveset trisodium
- Halaven
- Haldol
- Haldol Decanoate
- haloperidol
- haloperidol decanoate
- haloperidol lactate
- Invega
- Invega Sustenna
- Invirase
- Istodax
- Kaletra
- lapatinib
- Levaquin
- Levaquin In 5 % Dextrose
- levofloxacin
- levofloxacin in D5W
- Lexapro
- lopinavir-ritonavir
- methadone
- Methadone Intensol
- Methadose
- moxifloxacin
- moxifloxacin in NaCl (iso-osm)
- Nexavar
- nilotinib
- norfloxacin
- Noroxin
- Noxafil
- ondansetron
- ondansetron HCl
- ondansetron HCl (PF)
- paliperidone
- paliperidone palmitate
- pasireotide
- pazopanib
- posaconazole
- Potiga
- propafenone
- Qualaquin
- quetiapine
- quinine sulfate
- rilpivirine
- romidepsin
- Rythmol
- saquinavir mesylate
- Seroquel
- Seroquel Xr
- Signifor
- Sirturo
- sorafenib
- Sorine
- sotalol
- Sotalol Af
- Sprycel
- Synapryn
- Tasigna
- telavancin
- tetrabenazine
- Tikosyn
- tramadol
- tramadol-acetaminophen
- tramadol-glucosamine
- Trisenox
- Tykerb
- Ultracet
- Ultram
- Ultram Er
- Uroxatral
- vandetanib
- vemurafenib
- Versacloz
- Vibativ
- Votrient
- Xalkori
- Xenazine
- Zelboraf
- Zofran
- Zofran Odt
- Zuplenz
- None
Contraindicated
- Congenital long QT syndrome
- Doxorubicin-induced cardiomyopathy
- Hypokalemia
- Hypomagnesemia
- Neuroleptic malignant syndrome
- Prolonged QT interval
- Serotonin syndrome
Severe
Moderate
- Cardiac arrhythmia
GRANISETRON HCL (GRANISETRON HCL/PF)
- Prevention of chemotherapy-induced nausea and vomiting
- Post-operative nausea and vomiting
- Prevention of post-operative nausea and vomiting
- None
- Acute abdominal pain
- Constipation
- Fatigue
More Frequent
Severe
Less Severe
- Fever
- Prolonged QT interval
- Abnormal hepatic function tests
- Agitation
- Diarrhea
- Dizziness
- Drowsy
- Dysgeusia
- Dyspepsia
- General weakness
- Headache disorder
- Hypertension
- Hypotension
- Insomnia
- Symptoms of anxiety
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Anaphylaxis
- Atrial fibrillation
- Bradycardia
- Cardiac arrhythmia
- Chest pain
- Dyspnea
- Hypersensitivity drug reaction
- Pruritus of skin
- Sick sinus syndrome
- Skin rash
- Syncope
- Urticaria
Less Severe
- Palpitations
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
Granisetron (Inj)
Safety and efficacy not established, not studied age <2 years.
No safety and efficacy for use in post-op nausea and vomiting.
- 1 Day – 2 Years
- Safety and efficacy not established, not studied age <2 years.
- No safety and efficacy for use in post-op nausea and vomiting.
- 2 Years – 18 Years
- Safety and efficacy not established, not studied age <2 years.
- No safety and efficacy for use in post-op nausea and vomiting.
Granisetron
- Severity Level:
2
- Additional Notes: Insuff human data; animal data sug no known dev tox
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Granisetron
Insufficient data available.
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | Not known; no or inclusive data | Insufficient data available. |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
| Post-operative nausea and vomiting | |
| K91.0 | Vomiting following gastrointestinal surgery |
| R11.2 | Nausea with vomiting, unspecified |
| 0-9 | A-Z |
|---|---|
| K91.0 | Vomiting following gastrointestinal surgery |
| R11.2 | Nausea with vomiting, unspecified |
Formulary Reference Tool